PT97574A - Processo de obtencao de proteinas de superficie cd44 variaveis, sequencias do dna que as codificam, anticorpos destas proteinas, bem como a sua utilizacao no diagnostico e na terapia - Google Patents

Processo de obtencao de proteinas de superficie cd44 variaveis, sequencias do dna que as codificam, anticorpos destas proteinas, bem como a sua utilizacao no diagnostico e na terapia

Info

Publication number
PT97574A
PT97574A PT97574A PT9757491A PT97574A PT 97574 A PT97574 A PT 97574A PT 97574 A PT97574 A PT 97574A PT 9757491 A PT9757491 A PT 9757491A PT 97574 A PT97574 A PT 97574A
Authority
PT
Portugal
Prior art keywords
proteins
antibodies
diagnosis
therapy
code
Prior art date
Application number
PT97574A
Other languages
English (en)
Other versions
PT97574B (pt
Inventor
Peter Herrlich
Helmut Ponta
Ursula Gunthert
Siegfried Matzku
Achim Wenzel
Original Assignee
Deutsches Krebsfor Stiftung Oe
Kernforschungsz Karlsruhe
Univ Karlsruhe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsfor Stiftung Oe, Kernforschungsz Karlsruhe, Univ Karlsruhe filed Critical Deutsches Krebsfor Stiftung Oe
Publication of PT97574A publication Critical patent/PT97574A/pt
Publication of PT97574B publication Critical patent/PT97574B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2884—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD44
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
PT97574A 1990-05-07 1991-05-06 Processo de obtencao de proteinas de superficie cd44 variaveis, sequencias do dna que as codificam, anticorpos destas proteinas, bem como a sua utilizacao no diagnostico e na terapia PT97574B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4014510A DE4014510A1 (de) 1990-05-07 1990-05-07 Variante cd44-oberflaechenproteine, diese kodierende c-dna-sequenzen, antikoerper gegen diese proteine sowie ihre verwendung in der diagnostik und therapie

Publications (2)

Publication Number Publication Date
PT97574A true PT97574A (pt) 1992-01-31
PT97574B PT97574B (pt) 1998-08-31

Family

ID=6405813

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97574A PT97574B (pt) 1990-05-07 1991-05-06 Processo de obtencao de proteinas de superficie cd44 variaveis, sequencias do dna que as codificam, anticorpos destas proteinas, bem como a sua utilizacao no diagnostico e na terapia

Country Status (21)

Country Link
US (3) US5506119A (pt)
EP (1) EP0531300B1 (pt)
JP (1) JP3133062B2 (pt)
KR (1) KR0184691B1 (pt)
AT (1) ATE106943T1 (pt)
AU (1) AU646858B2 (pt)
BR (1) BR1100650A (pt)
CA (1) CA2082382C (pt)
DE (2) DE4014510A1 (pt)
DK (1) DK0531300T3 (pt)
FI (1) FI106128B (pt)
HU (1) HU218905B (pt)
IE (1) IE62096B1 (pt)
IL (3) IL98024A (pt)
NO (3) NO309770B1 (pt)
NZ (1) NZ238056A (pt)
PT (1) PT97574B (pt)
TW (1) TW212202B (pt)
WO (1) WO1991017248A1 (pt)
YU (1) YU49126B (pt)
ZA (1) ZA913389B (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002873A (en) * 1989-03-17 1991-03-26 Fred Hutchinson Cancer Research Center DNA sequence encoding a lymphocyte adhesion receptor for high endothelium
US5443750A (en) * 1991-01-16 1995-08-22 The Procter & Gamble Company Detergent compositions with high activity cellulase and softening clays
DE4134982A1 (de) * 1991-10-23 1993-04-29 Kernforschungsz Karlsruhe Verwendung von antikoerper enthaltenden praeparationen zur immunsuppression
US5830646A (en) * 1992-07-21 1998-11-03 Isis Innovation Limited Diagnostic method
EP0703989B1 (en) 1993-06-18 1997-11-05 Oy Biotie Therapies COMPOSITIONS AND DIAGNOSTIC METHODS USING MONOCLONAL ANTIBODIES AGAINST CD44v6
DE4320624A1 (de) * 1993-06-22 1995-02-09 Boehringer Ingelheim Int Verfahren zur Diagnose und Analyse von Mammakarzinomen
EP0767378A1 (de) * 1993-06-22 1997-04-09 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verfahren zur Diagnose und Analyse von Magenkarzinomen
DE4320623C2 (de) * 1993-06-22 1997-11-20 Boehringer Ingelheim Int Verfahren zur Diagnose und Analyse von Adenokarzinomen
DE4326573A1 (de) * 1993-08-07 1995-02-23 Boehringer Ingelheim Int Durch Exon v5 des CD44-Gens kodierte Polypeptide als Targets für Immuntherapie und Immunszintigraphie von Tumoren
DE4431297A1 (de) * 1994-09-02 1996-03-07 Boehringer Ingelheim Int Monoklonaler Antikörper gegen CD44v6
DE19540515C1 (de) * 1995-10-31 1997-02-06 Boehringer Ingelheim Int Tumortherapie durch adoptiven Transfer CD44v-spezifischer zytotoxischer T-Lymphozyten
DE19653607A1 (de) 1996-12-20 1998-06-25 Boehringer Ingelheim Int Verfahren zur Diagnose und Therapie von Hodgkin-Lymphomen
DE19708713C2 (de) * 1997-03-04 2002-11-28 Boehringer Ingelheim Int Verwendung von anti-CD44 Antikörpern enthaltenden Präparationen zur Behandlung bestimmter Tumore und zur Unterdrückung von Immunreaktionen
US8048416B2 (en) * 1999-10-08 2011-11-01 Hoffmann-La Roche Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US20080124327A1 (en) * 1999-10-08 2008-05-29 Arius Research, Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US8071072B2 (en) 1999-10-08 2011-12-06 Hoffmann-La Roche Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US7947496B2 (en) 1999-10-08 2011-05-24 Hoffmann-La Roche Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US7189397B2 (en) * 1999-10-08 2007-03-13 Arius Research Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US20050100542A1 (en) * 1999-10-08 2005-05-12 Young David S. Cytotoxicity mediation of cells evidencing surface expression of CD44
US20090004103A1 (en) * 1999-10-08 2009-01-01 Young David S F Cytotoxicity mediation of cells evidencing surface expression of CD44
DE10026833A1 (de) * 2000-05-30 2001-12-13 Karlsruhe Forschzent Verfahren zur Identifizierung von Verbindungen zur Modulierung der Aktivität eines Tumorsuppressorgens
AU2003272511A1 (en) * 2002-09-13 2004-04-30 Dyax Corporation Cd44-binding ligands
DK2886126T3 (en) 2013-12-23 2017-09-18 Exchange Imaging Tech Gmbh Nanoparticle conjugated to CD44-binding peptides
CN109608537B (zh) * 2018-12-12 2020-09-15 深圳市龙华区人民医院 基于前列腺癌干细胞标志物cd44的抗原表位多肽cd44-p2及其应用
CN109608536B (zh) * 2018-12-12 2020-09-15 深圳市龙华区人民医院 基于前列腺癌干细胞标志物cd44的抗原表位多肽cd44-p3及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4753894A (en) * 1984-02-08 1988-06-28 Cetus Corporation Monoclonal anti-human breast cancer antibodies
US5108904A (en) * 1990-03-26 1992-04-28 Alan Landay CD44 as a marker for HIV infection

Also Published As

Publication number Publication date
YU79491A (sh) 1994-06-10
US5506119A (en) 1996-04-09
NO924234D0 (no) 1992-11-04
FI925043A (fi) 1992-11-06
NO20001668L (no) 1993-05-06
IL134982A (en) 2004-05-12
DE4014510A1 (de) 1991-11-14
DE59101889D1 (de) 1994-07-14
IL134982A0 (en) 2001-05-20
KR0184691B1 (ko) 1999-04-01
WO1991017248A1 (de) 1991-11-14
AU646858B2 (en) 1994-03-10
NO317154B1 (no) 2004-08-30
EP0531300A1 (de) 1993-03-17
IE911526A1 (en) 1991-11-20
CA2082382A1 (en) 1991-11-08
IL98024A (en) 2001-06-14
JPH05508309A (ja) 1993-11-25
NO980293D0 (no) 1998-01-23
IL98024A0 (en) 1992-06-21
DK0531300T3 (da) 1994-10-10
NO309770B1 (no) 2001-03-26
CA2082382C (en) 2008-09-30
FI106128B (fi) 2000-11-30
BR1100650A (pt) 2000-08-08
US5760178A (en) 1998-06-02
JP3133062B2 (ja) 2001-02-05
NO20001668D0 (no) 2000-03-31
YU49126B (sh) 2004-03-12
ZA913389B (en) 1992-03-25
FI925043A0 (fi) 1992-11-06
NO980293L (no) 1993-01-04
HU218905B (hu) 2000-12-28
EP0531300B1 (de) 1994-06-08
US5885575A (en) 1999-03-23
HU9203449D0 (en) 1993-01-28
PT97574B (pt) 1998-08-31
HUT63652A (en) 1993-09-28
ATE106943T1 (de) 1994-06-15
NO924234L (no) 1993-01-04
TW212202B (pt) 1993-09-01
AU7565991A (en) 1991-11-27
NZ238056A (en) 1993-01-27
IE62096B1 (en) 1995-01-11
NO310661B1 (no) 2001-08-06

Similar Documents

Publication Publication Date Title
PT97574A (pt) Processo de obtencao de proteinas de superficie cd44 variaveis, sequencias do dna que as codificam, anticorpos destas proteinas, bem como a sua utilizacao no diagnostico e na terapia
ATE80660T1 (de) Verfahren zur herstellung eines polypeptides.
BR9507618A (pt) Frações polipeptidicas solúveis da proteína lag-3 processo de produção composição terapêutica anticorpos anti-idiotipo
ES2147178T3 (es) Dominio de union a cd2 del antigeno 3 asociado con la funcion linfocitica.
ES2068907T3 (es) Secuencias de nucleotidos que codifican una proteina con actividad ureasica.
ATE106454T1 (de) Kennzeichnung und nachweis von mit autoimmunkrankheiten assoziierten sequenzen.
DE3587422D1 (de) Fuer ein hirudinaehnliches protein kodierende dns-sequenz und verfahren zur herstellung eines solchen proteins.
ATE135371T1 (de) Mit akuter pankreatitis assoziiertes protein, mittel zur diagnose von akuter pankreatitis
ATE212059T1 (de) Methoden zur identifizierung heterofunktionaler fusionsproteine
DE69233463D1 (de) Expression und reinigung von kloniertem humanen alpha-fetoprotein
ATE121754T1 (de) Vakzine gegen bordetella.
NO930428D0 (no) Proteinstrukturen til plantetoksingelonin
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
SE8904007D0 (sv) Monoklona antikroppar och diagnostiseringsmetod
ATE188997T1 (de) Klonierung von malaria-spezifischen dna- sequenzen:isolierung des gens für das 140 kd protein
DE68917520D1 (de) Verfahren und Systeme zur Herstellung von HIV-Antigenen.
ATE290549T1 (de) Ing2, ein mit iaps assoziiertes zellzyklusprotein,sowie zusammensetzungen, verfahren und verwendungen
ATE88639T1 (de) Antigenisches peptid der 28kd proteingruppe aus s. mansoni und sein verfahren zur isolierung, monoklonale antikoerper, die mindestens ein epitop dieses peptids erkennen und verwendungen fuer die induzierung der synthese von neutralisierenden antikoerpern.
ATE91303T1 (de) Verfahren zur herstellung von peptiden durch spezifische spaltung von gentechnisch gewonnenen fusionsproteinen mit collagenasen.

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19911004

FG3A Patent granted, date of granting

Effective date: 19980519

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20061120